FAQs ABOUT AFANAT 30 TABLET
What AFANAT 30 TABLET is used for?
AFANAT 30 TABLET is an anticancer drug used to treat metastatic and squamous non-small cell lung cancer as a first line of treatment or if prior chemotherapy treatment is insufficient to provide cure in adult patients. Non-small cell lung cancer (NSCLC) is a type of cancer that occurs in the lung when abnormal cells form and multiply into large mass forming tumor or lesions characterized by persistent cough, shortness of breath, weight loss or coughing up blood.
How AFANAT 30 TABLET works on my body?
AFANAT 30 TABLET works by blocking the activity of a group of proteins called ErbB1, ErbB2 (HER2), ErbB3 and ErbB4 in the cancer cells which are required for the growth and spread of cancer cells in the lungs.
What precautions do I need to follow while taking AFANAT 30 TABLET?
Patients taking AFANAT 30 TABLET must inform their doctor about their pre-existing disease conditions related to eye, lung, heart, kidney, liver problems since it may cause some unwanted side effects.
What are the side effects of AFANAT 30 TABLET?
The most common side effects of taking AFANAT 30 TABLET are decreased appetite, decreased weight, diarrhea, nausea, vomiting, dry skin, pain or peeling of skin (hands and feet), allergic reactions (such as runny nose, rash, itching, inflammation of the lip, mouth sores), stomach pain, indigestion, heartburn, eye irritation, and fever. Consult your doctor for advice if your symptoms get worsen over the time.
Is AFANAT 30 TABLET safe to use in children?
No. AFANAT 30 TABLET is not recommended for use in children and adolescents (below 18 years of age). If AFANAT 30 TABLET is accidentally ingested by a child or adolescent, go to the hospital immediately and consult the doctor for further management.
Can AFANAT 30 TABLET be taken by pregnant or breastfeeding women?
AFANAT 30 TABLET is not recommended for use in pregnant women since it may cause fetal harm. Women of childbearing potential should use effective birth control during treatment and should continue it for at least next 2 weeks after receiving the last dose of AFANAT 30 TABLET. The medicine is not recommended for use in breast-feeding women and advised not to breast feed while taking AFANAT 30 TABLET and for 2 weeks after taking the last dose of AFANAT 30 TABLET.